Vaspin, a Compensatory Mechanism Against High Glucose Levels Since Birth?

Journal Title: Journal of Clinical Research in Pediatric Endocrinology - Year 2019, Vol 11, Issue 2

Abstract

Objective: Hormones produced by fat tissue, adipokines, produced during intrauterine life have recently been implicated in fetal growth. Vaspin is an adipokine expressed in visceral adipose tissue and has insulin-sensitizing effects. Elevated serum vaspin concentrations are associated with alterations in insulin sensitivity. We aimed to determine if vaspin concentrations in cord blood from healthy, term newborns differ among those born small for gestational age (SGA), appropriate for gestational age (AGA), and large for gestational age (LGA). A secondary objective was to determine whether an association existed between vaspin and anthropometric measurements, glucose and insulin levels in the newborn. Methods: The study population included healthy term newborns, 30 subjects in the SGA, 12 in the AGA, and 34 in the LGA group. Anthropometry was documented in all subjects. Blood was taken from the umbilical cord vein from each child for later analysis for vaspin, insulin and glucose concentrations. Results: Cord blood vaspin, insulin and glucose concentrations were not different between the three study groups. A negative correlation between vaspin and glucose concentrations was demonstrated in the whole cohort (r=-0.364, p=0.001). This correlation was also observed in the LGA group (r=-0.482, p=0.004). Glucose concentrations significantly predicted vaspin concentrations (r2=0.132, p=0.001). Conclusion: We found a negative association between glucose and vaspin concentrations in umbilical cord blood. In addition there was a predictive association between blood glucose and resulting vaspin concentration, suggesting that vaspin can be used as a predictor of alterations in the insulin-glucose metabolism from birth.

Authors and Affiliations

Citlalli E. Hernández-Rodríguez, Cynthia M. Estrada Zúñiga, Manuel E. De la O-Cavazos, Fernando F. Montes-Tapia, Patricia Gerez-Martínez, Fernando J. Lavalle-González, Consuelo Treviño Garza

Keywords

Related Articles

Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases

Hyponatremia is the most common electrolyte disorder among hospitalized patients and it is sometimes considered as a poor outcome predictor. Its correction is thus indicated, even in asymptomatic patients. The convention...

Follow-up Findings in a Turkish Girl with Pseudohypoparathyroidism Type Ia Caused by a Novel Heterozygous Mutation in the GNAS Gene

Pseudohypoparathyroidism type Ia (PHP-Ia) is characterized by multihormone resistance and an Albright hereditary osteodystrophy (AHO) phenotype. It is caused by heterozygous mutations in GNAS gene. Clinical and biochemic...

The Role of Irisin, Insulin and Leptin in Maternal and Fetal Interaction

Objective: Insulin is an important hormone for intrauterine growth. Irisin is an effective myokine in the regulation of physiological insulin resistance in pregnancy. Leptin and insulin are associated with fetal growth a...

Melanocortin-4 Receptor Gene Mutations in a Group of Turkish Obese Children and Adolescents

Objective: Melanocortin-4 receptor (MC4R) mutations are the most common known cause of monogenic obesity. Data regarding MC4R mutations in Turkish subjects are limited. To determine the prevalence of MC4R mutations in a...

Hypogonadotropic Hypogonadism due to Novel FGFR1 Mutations

Objective: The underlying genetic etiology of hypogonadotropic hypogonadism (HH) is heterogeneous. Fibroblast growth factor signaling is pivotal in the ontogeny of gonadotropin-releasing hormone neurons. Loss-of-function...

Download PDF file
  • EP ID EP581671
  • DOI 10.4274/jcrpe.galenos.2018.2018.0141
  • Views 187
  • Downloads 0

How To Cite

Citlalli E. Hernández-Rodríguez, Cynthia M. Estrada Zúñiga, Manuel E. De la O-Cavazos, Fernando F. Montes-Tapia, Patricia Gerez-Martínez, Fernando J. Lavalle-González, Consuelo Treviño Garza (2019). Vaspin, a Compensatory Mechanism Against High Glucose Levels Since Birth?. Journal of Clinical Research in Pediatric Endocrinology, 11(2), 125-131. https://www.europub.co.uk/articles/-A-581671